title: [Autologous bone marrow-derived mesenchymal stem cells and peripheral blood stem cells cotransplantation in treatment of hematological malignant diseases].
abstract: OBJECTIVE
  To explore the feasibility and safety of cotransplantation of autologous bone marrow-derived mesenchymal stem cells (MSCs) and peripheral blood stem cells in hematological malignant diseases and to observe its effect on hematopoietic reconstruction after cotransplantation.
  
  
  METHODS
  Adult human MSCs were isolated from the healthy bone marrow of the patient himself with Percoll (1.073 g/ml) and cultured in Dulbecco's modified Eagle's medium with low glucose containing 10% AB type human serum. After conditioning regimen of high-dose chemotherapy and radiotherapy, cotransplantation of autologous bone marrow-derived MSCs and peripheral blood stem cells was done in five patients with hematological malignant diseases.
  
  
  RESULTS
  The process of the infusion was safe and there were no adverse reactions or other toxicities related to the infusion of MSCs. The median time to achieve neutrophil counts greater than 0.5x10(9)/L was 9.4 days (ranging from 8 to 11 days) after cotransplantation and platelet counts greater than 20x10(9)/L 12.2 days (ranging from 10 to 14 days).
  
  
  CONCLUSIONS
  Cotransplantation of autologous bone marrow-derived MSCs and peripheral blood stem cells in hematological malignant diseases is feasible and safe. The rapid hematopoietic reconstruction after cotransplantation shows that MSCs have an effect on hematopoiesis, but the mechanism is still to be investigated.
authors.affiliation: The Hematology Center of PLA, Lanzhou General Hospital, Lanzhou Command, PLA, Lanzhou 730050, China.
authors.forename: Tao
authors.initials: T
authors.lastname: Wu
authors.forename: Hai
authors.initials: H
authors.lastname: Bai
authors.forename: Cun-bang
authors.initials: CB
authors.lastname: Wang
authors.forename: Qian
authors.initials: Q
authors.lastname: Zhang
authors.forename: Lin-fang
authors.initials: LF
authors.lastname: Tantai
authors.forename: Xiao-jing
authors.initials: XJ
authors.lastname: Wang
authors.forename: Jian-feng
authors.initials: JF
authors.lastname: Ou
authors.forename: Qiang
authors.initials: Q
authors.lastname: Zhao
mesh_terms: D000328:Adult; D001855:Bone Marrow Diseases / Q000601:surgery; D006402:Hematologic Diseases / Q000601:surgery*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D008875:Middle Aged; D014182:Transplantation, Autologous